XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Number of shares of common stock
Common stock and additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2022   534.0      
Beginning balance at Dec. 31, 2022 $ 3,661   $ 32,514 $ (28,622) $ (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,841     2,841  
Other comprehensive income (loss), net of taxes (37)       (37)
Dividends declared on common stock (1,138)     (1,138)  
Issuance of common stock in connection with equity award programs (in shares)   0.3      
Issuance of common stock in connection with equity award programs 11   11    
Stock-based compensation expense 47   47    
Tax impact related to employee stock-based compensation expense (37)   (37)    
Ending balance (in shares) at Mar. 31, 2023   534.3      
Ending balance at Mar. 31, 2023 5,348   32,535 (26,919) (268)
Beginning balance (in shares) at Dec. 31, 2022   534.0      
Beginning balance at Dec. 31, 2022 3,661   32,514 (28,622) (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 5,950        
Other comprehensive income (loss), net of taxes 105        
Ending balance (in shares) at Sep. 30, 2023   535.1      
Ending balance at Sep. 30, 2023 7,656   32,753 (24,971) (126)
Beginning balance (in shares) at Mar. 31, 2023   534.3      
Beginning balance at Mar. 31, 2023 5,348   32,535 (26,919) (268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,379     1,379  
Other comprehensive income (loss), net of taxes (12)       (12)
Issuance of common stock in connection with equity award programs (in shares)   0.6      
Issuance of common stock in connection with equity award programs 16   16    
Stock-based compensation expense 119   119    
Tax impact related to employee stock-based compensation expense (69)   (69)    
Ending balance (in shares) at Jun. 30, 2023   534.9      
Ending balance at Jun. 30, 2023 6,781   32,601 (25,540) (280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,730     1,730  
Other comprehensive income (loss), net of taxes 154       154
Dividends declared on common stock (1,161)     (1,161)  
Issuance of common stock in connection with equity award programs (in shares)   0.2      
Issuance of common stock in connection with equity award programs 33   33    
Stock-based compensation expense 124   124    
Tax impact related to employee stock-based compensation expense (5)   (5)    
Ending balance (in shares) at Sep. 30, 2023   535.1      
Ending balance at Sep. 30, 2023 $ 7,656   32,753 (24,971) (126)
Beginning balance (in shares) at Dec. 31, 2023 535.4 535.4      
Beginning balance at Dec. 31, 2023 $ 6,232   33,070 (26,549) (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (113)     (113)  
Other comprehensive income (loss), net of taxes 99       99
Dividends declared on common stock (1,208)     (1,208)  
Issuance of common stock in connection with equity award programs (in shares)   1.0      
Issuance of common stock in connection with equity award programs 34   34    
Stock-based compensation expense 103   103    
Tax impact related to employee stock-based compensation expense (125)   (125)    
Ending balance (in shares) at Mar. 31, 2024   536.4      
Ending balance at Mar. 31, 2024 $ 5,022   33,082 (27,870) (190)
Beginning balance (in shares) at Dec. 31, 2023 535.4 535.4      
Beginning balance at Dec. 31, 2023 $ 6,232   33,070 (26,549) (289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 3,463        
Other comprehensive income (loss), net of taxes $ (47)        
Ending balance (in shares) at Sep. 30, 2024 537.5 537.5      
Ending balance at Sep. 30, 2024 $ 7,527   33,393 (25,530) (336)
Beginning balance (in shares) at Mar. 31, 2024   536.4      
Beginning balance at Mar. 31, 2024 5,022   33,082 (27,870) (190)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 746     746  
Other comprehensive income (loss), net of taxes 35       35
Issuance of common stock in connection with equity award programs (in shares)   0.8      
Issuance of common stock in connection with equity award programs 65   65    
Stock-based compensation expense 157   157    
Tax impact related to employee stock-based compensation expense (100)   (100)    
Ending balance (in shares) at Jun. 30, 2024   537.2      
Ending balance at Jun. 30, 2024 5,925   33,204 (27,124) (155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,830     2,830  
Other comprehensive income (loss), net of taxes (181)       (181)
Dividends declared on common stock (1,236)     (1,236)  
Issuance of common stock in connection with equity award programs (in shares)   0.3      
Issuance of common stock in connection with equity award programs 67   67    
Stock-based compensation expense 136   136    
Tax impact related to employee stock-based compensation expense $ (14)   (14)    
Ending balance (in shares) at Sep. 30, 2024 537.5 537.5      
Ending balance at Sep. 30, 2024 $ 7,527   $ 33,393 $ (25,530) $ (336)